High Quality Reagents


17 07, 2019

KTP Associate Conference 2019 (20-21 June | Belfast, UK)

2019-07-17T10:34:10+00:00July 17th, 2019|News|

KTP Associate Conference 2019 (20-21 June | Belfast, UK) Dr Abdo Alnabulsi, KTP Associate Vertebrate Antibodies Ltd-University of Aberdeen, attended the KTP Associate Conference in Belfast, UK. Abdo Alnabulsi gave a presentation entitled: The Development of Antibodies and Characterisation of Novel Prognostic Biomarkers in Colorectal Cancer. [...]

16 04, 2019

Vertebrate Antibodies Joins Forces with Forsage Holdings Ltd

2019-04-16T14:28:33+00:00April 16th, 2019|News|

March 2019- Joining forces with Forsage Holdings Ltd VERTEBRATE ANTIBODIES LTD (VAL) is delighted to announce a Strategic Alliance with Forsage Holdings Ltd (FH) Forsage Holdings Ltd is a dynamic and growth focused Irish family owned private Investment Company with investments in established and fast evolving [...]

8 04, 2019

Vertebrate Antibodies & Marinnovac Collaboration

2019-04-16T14:23:58+00:00April 8th, 2019|News|

Animal Pharm: The Vertebrate Antibodies and Marinnovac Collaboration The new firm is based in O Porriño, Spain. It is aiming to fast-track fish and shrimp disease prevention strategies through collaborations. The firm's focus is on autogenous, experimental and licensed vaccines, as well as diagnostic services. The [...]

28 03, 2019

Grants and Announcements

2019-04-05T10:20:42+00:00March 28th, 2019|News|

A Timeline of Our Grants and Announcements May 2017 - ISCF Agri-food technology catalyst seeding catalyst award Vertebrate Antibodies in collaboration with Professor Sam Martin at Aberdeen University have secured a BBSRC SEEDING CATALYST AWARD to support a project on developing [...]

8 03, 2019

Vertebrate Antibodies – Publications

2019-03-21T13:03:12+00:00March 8th, 2019|News|

Vertebrate Antibodies - Publications Alnabulsi A, Cash B, Hu Y, Silina L, Alnabulsi A, Murray GI (2019). The expression of brown fat associated proteins in colorectal cancer and the relationship of uncoupling protein 1 with prognosis. Int J Cancer. PMID: 30737786. DOI: 10.1002/ijc.32198. Veenstra KA, Alnabulsi [...]

4 01, 2018

April 2017 – A landmark milestone

2018-08-01T14:20:33+00:00January 4th, 2018|News|

VAL products catalogue has passed the 150 mark. The antibodies are towards key targets within a wide range of organisms for research and clinical applications, all of which are currently available for licensing from Cancer Research Technology at their Ximbio site (https://ximbio.com/organisation/48/vertebrate-antibodies-limited).

4 01, 2018

March 2016 – Development of monoclonal antibodies to monitor animal’s health as part of European project

2018-08-01T14:24:31+00:00January 4th, 2018|News|

VetBioNet is a European project funded under a call from Horizon 2020 for funding large research infrastructures. VetBioNet (http://www.vetbionet.eu/) overarching goal is to establish and maintain a comprehensive network of pre-eminent high-containment (BSL3) research facilities, academic institutes, international organisations and industry partners that is dedicated to advance research [...]

21 10, 2016

April 2015

2018-08-01T14:25:34+00:00October 21st, 2016|News|

April 2015 – Development of monoclonal antibodies for parasite-specific molecules In April 2015 a European Union Horizon 2020 Project funded to support the prospective fish-farming industry has started. ParaFishControl (www.parafishcontrol.eu) overarching goal is to increase the sustainability and competitiveness of the European aquaculture industry by improving our understanding [...]

13 11, 2014

October 2014

2018-08-01T14:26:15+00:00November 13th, 2014|News|

VAL new antibodies towards key zebrafish targets: The antibodies are specific to zebrafish targets involved in key biological pathways including immunity, angiogenesis, tumour suppressors and drug metabolisers. The list are as follows; CD4, FOXP3, IFNγ(1), p53, MMP9, AKT1, FLT1, FGF1, TIMP2a, PXR and CYP3C1. Datasheets available on the [...]

Go to Top